09/16/2025 | News release | Distributed by Public on 09/16/2025 07:34
If you're being treated for primary hypothyroidism but are still experiencing symptoms, you might consider enrolling in the AVANTI Study of an investigational medication.
Are you 18-75 years of age-
Have you been diagnosed with primary hypothyroidism for at least 12 months-
Have you been on continuous thyroid replacement therapy with an FDA approved dose of Synthroid or Levothyroxine for at least 12 months, and at a stable dose for at least 3 monthsetic T4
New thyroid study now enrolling.
For more information, call Debbie Clark at 901-448-2676 or email her at [email protected].